Atroposelective Chan–Evans–Lam Amination
The synthetic control of atropoisomerism along C−N bonds is a major challenge, and methods that allow C−N atroposelective bond formation are rare. This is a problem because each atropoisomer can feature starkly differentiated biological properties. Yet, among the three most practical and applicable...
Saved in:
Published in: | Chemistry : a European journal 2024-03, Vol.30 (16), p.e202304378-n/a |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The synthetic control of atropoisomerism along C−N bonds is a major challenge, and methods that allow C−N atroposelective bond formation are rare. This is a problem because each atropoisomer can feature starkly differentiated biological properties. Yet, among the three most practical and applicable classical amination methods available: 1) the Cu‐catalyzed Ullmann–Goldberg reaction, 2) the Pd‐catalyzed Buchwald–Hartwig reaction, and 3) the Cu‐catalyzed Chan–Evans–Lam reaction, none has truly been rendered atroposelective at the newly formed C−N bond. The first ever Chan–Evans–Lam atroposelective amination is herein described with a simple copper catalyst and newly designed PyrOx chiral ligand. This method should find important applications in asymmetric synthesis, in particular for medicinal chemistry.
The first and long elusive atroposelective Chan–Evans–Lam C−N coupling is herein described. This strategy should find important applications for the enantioselective synthesis of bioactive compounds containing hindered carbon‐nitrogen bonds. |
---|---|
ISSN: | 0947-6539 1521-3765 |